ArticleLife (Basel, Switzerland)2026

Impact of PD-L1 Status on the Development of Cutaneous Immune-Related Adverse Events in Non-Small-Cell Lung Cancer Patients Receiving Immunotherapy.

Alexander Yakobson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.